You are here
Aptose to Present at the 8th Annual SVB Leerink Global Healthcare Conference
SAN DIEGO and TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, and Gregory K. Chow, Senior Vice President and Chief Financial Officer, will participate at the upcoming 8th Annual SVB Leerink Global Healthcare Conference on Friday, March 1st, 2019 at 11:30 a.m. ET in New York, NY.
Tuesday, February 19, 2019 - 07:30